Cite
HARVARD Citation
Butt, A. et al. (n.d.). Effectiveness and Safety of Sofosbuvir/Ledipasvir and Paritaprevir/ritonavir/Ombitasvir + Dasabuvir in Patients with Chronic Kidney Diseases: Results from ERCHIVES. Open forum infectious diseases. pp. S196-S197. [Online].